Multi-Timeframe (MTF) Analysis
HTF (Higher Timeframe) → Yearly, Half-Yearly, and Quarterly all show UPTREND with strong support around 1139–1309.
Average = 1321 (long-term base demand).
MTF (Medium Timeframe) → Monthly, Weekly, and Daily also UP, with demand zones tightening at 2037–2725.
Average = 2360 (medium-term strong demand).
ITF (Intraday Timeframe) → 60M–240M also UP, clustered demand around 2872–2907.
Average = 2890 (short-term demand).
👉 Overall alignment: All timeframes are in UPTREND, so the structure is bullish.
📈 Trade Plan
Entry-1: 2725
Stop Loss (SL): 2513 (≈8% risk)
Target: 4534 (≈66% reward)
Risk per share: 212
Reward per share: 1809
Risk-Reward Ratio (RR): 8.53 (very favorable)
💰 Capital & Profitability
Qty: 1000 shares → Total Buy Value = 2,725,000
Brokerage + Taxes: 0.49% → ₹13,357
Profit if target hits: 1,809,000
Net Profit after costs: 1,795,643
Loss if SL hits: 225,357
Net RR: 7.97 (still excellent).
📊 ROI & Leverage
Capital Value considered: 953,750 (MTF 65%)
Leverage effect: Only ~35% of cash deployed, rest financed.
ROI in 4 months (if target hit): 182% after deducting interest.
⚠️ Key Observations
Entry zone (2725) is close to Daily demand (2725–2513). Good location.
SL (2513) sits at lower edge of daily demand → smart protection.
Target (4534) is ~50% higher than Last High (3060) → aggressive but supported by structure.
Risk very low vs reward, but you must watch minor supply at 18,100 (highlighted in sheet).
Leverage used (65%) amplifies returns, but also increases sensitivity to SL hit.
✅ Conclusion:
This is a highly asymmetric bullish trade. With all MTFs aligned UP, entry near demand, and a stellar RR (8.5+), the plan is strong. The only caution is the stretch in target (4534) — it requires sustained trend continuation. Managing partial profits near 3060 (previous high) could derisk while still aiming for extended targets.
HTF (Higher Timeframe) → Yearly, Half-Yearly, and Quarterly all show UPTREND with strong support around 1139–1309.
Average = 1321 (long-term base demand).
MTF (Medium Timeframe) → Monthly, Weekly, and Daily also UP, with demand zones tightening at 2037–2725.
Average = 2360 (medium-term strong demand).
ITF (Intraday Timeframe) → 60M–240M also UP, clustered demand around 2872–2907.
Average = 2890 (short-term demand).
👉 Overall alignment: All timeframes are in UPTREND, so the structure is bullish.
📈 Trade Plan
Entry-1: 2725
Stop Loss (SL): 2513 (≈8% risk)
Target: 4534 (≈66% reward)
Risk per share: 212
Reward per share: 1809
Risk-Reward Ratio (RR): 8.53 (very favorable)
💰 Capital & Profitability
Qty: 1000 shares → Total Buy Value = 2,725,000
Brokerage + Taxes: 0.49% → ₹13,357
Profit if target hits: 1,809,000
Net Profit after costs: 1,795,643
Loss if SL hits: 225,357
Net RR: 7.97 (still excellent).
📊 ROI & Leverage
Capital Value considered: 953,750 (MTF 65%)
Leverage effect: Only ~35% of cash deployed, rest financed.
ROI in 4 months (if target hit): 182% after deducting interest.
⚠️ Key Observations
Entry zone (2725) is close to Daily demand (2725–2513). Good location.
SL (2513) sits at lower edge of daily demand → smart protection.
Target (4534) is ~50% higher than Last High (3060) → aggressive but supported by structure.
Risk very low vs reward, but you must watch minor supply at 18,100 (highlighted in sheet).
Leverage used (65%) amplifies returns, but also increases sensitivity to SL hit.
✅ Conclusion:
This is a highly asymmetric bullish trade. With all MTFs aligned UP, entry near demand, and a stellar RR (8.5+), the plan is strong. The only caution is the stretch in target (4534) — it requires sustained trend continuation. Managing partial profits near 3060 (previous high) could derisk while still aiming for extended targets.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.